MedPath

Japan-Drug Eluting Stents Evaluation; a Randomized Trial

Not Applicable
Completed
Conditions
Coronary Artery Disease
Interventions
Device: TAXUS stent
Device: Cypher stent
Registration Number
NCT00708669
Lead Sponsor
Associations for Establishment of Evidence in Interventions
Brief Summary

To evaluate the procedural, short and long term clinical outcomes of the TAXUS stent compared to Cypher stent in coronary arteries of ≥ 2.5 and ≤ 3.75 mm in the reference vessel diameter with a lesion of ≤ 46 mm (by visual observation) in routine clinical settings in Japan.

Detailed Description

In these days, meta-analyses have been conducted in large scale and small scale studies, but there has been no conclusion yet stating which one of the stents, either Cypher stent or TAXUS stent, is superior to the other. In specific disease condition such as in diabetic patients, it has been reported that Paclitaxel (TAXUS stent) is more suitable than Sirolimus (Cypher stent), due to the difference in the action mechanisms of the drugs. Since TAXUS stent was recently approved in Japan, we decided to conduct a randomized multi-center comparative study to compare Cypher stent and TAXUS stent regarding the clinical endpoint (target vessel failure for 8 months). The study is powered to show equivalence between the 2 stents in all patients, and to show superiority of the TAXUS stent in the diabetic patient population. In addition, for selected patients, quantitative coronary angiography, intravascular ultrasound, optical coherence tomography, and angioscopy are performed to examine the difference of the two stents more closely.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3500
Inclusion Criteria
  • Patient is ≥ 20 years old
  • Patient suitable for percutaneous coronary intervention (PCI)
  • Patient with signed informed consent
  • Patient judged suitable to receive anti-platelet drugs (clopidogrel bisulfate or ticlopidine hydrochloride, etc.) in principle for at least 6 months after procedure, and ideally up to 12 months in patients who are not at high risk of bleeding, based on ACC/AHA guideline
  • Patient with up to 3 lesions (with ≥ 50% of stenosis) in the maximum of 2 targeted vessels to be treated at once
  • Patient with reference vessel diameter (RVD) of 2.5 mm to 3.75 mm by visual observation
  • Patient with length of each lesion of up to 46 mm by visual assessment
  • Patient eligible for implementation of drug eluting stent.
Exclusion Criteria
  • Patient with any planned treatment in the targeted vessel with a drug eluting stent other than in this study
  • Patient with acute myocardial infarction (AMI) (including non-ST segment elevation MI) developed within 7 days before the procedure
  • Patient participating in a currently ongoing registry or clinical study, or receiving a treatment which may affect the endpoints of this study
  • Patient of childbearing potential with a positive pregnancy test within 14 days before the procedure, or lactating
  • Patient who has history of allergy against Sirolimus, Paclitaxel, polymers or stainless steel
  • Patient who has history of side-effect against anti-platelet drugs or anti-coagulation drugs
  • Patient with serious hepatic dysfunction
  • Patient with left ventriculogram ejection fraction of 35% or less
  • Patient with three target vessels in need of PCI treatment
  • Patient with serious renal dysfunction (serum creatinine value 2mg/dL or higher)
  • Patient currently receiving artificial dialysis
  • Patient with a malignant tumor (cancer) diagnosed within 5 years before the procedure
  • Patient who has received PCI treatment within the past one year
  • Patient with chronic total occlusion (CTO) or TIMI flow 2 or less
  • Patient with >50% stenosis in left main coronary artery
  • Patient with >50% stenosis in side branch ostial for which stenting in the side branch lesion is required (KBT for side branch is accepted)
  • Patient with in-stent restenosis in the target lesion implanted with a bare-metal or drug eluting stent
  • Patient who has target lesion in saphenous vein graft
  • Patient judged non-eligible by the physician in charge.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TAXUS groupTAXUS stent-
Cypher groupCypher stent-
Primary Outcome Measures
NameTimeMethod
Target Vessel Failure (TVF) at 8 months post-procedure(assessed prior to routine angiography) in Overall study population8 months
Secondary Outcome Measures
NameTimeMethod
Target Vessel Failure (TVF) at 8 months post-procedure (assessed prior to routine angiography) in diabetic group8 months

Trial Locations

Locations (122)

Caress Sapporo Tokeidai Hospital

🇯🇵

Sapporo, Japan

Juntendo University Nerima Hospital

🇯🇵

Tokyo, Japan

Toho University Omori Medical Center

🇯🇵

Tokyo, Japan

Fukuoka University Hospital

🇯🇵

Fukuoka, Japan

Gifu Prefectural General Medical Center

🇯🇵

Gifu, Japan

Seirei Hamamatsu General Hospital

🇯🇵

Hamamatsu, Japan

Kawasaki Saiwai Hospital

🇯🇵

Kawasaki, Japan

Nagoya daiichi red cross Hospital

🇯🇵

Nagoya, Japan

Kitasato University Hospital

🇯🇵

Sagamihara, Japan

Toyohashi Heart Center

🇯🇵

Toyohashi, Japan

Aichi Medical University Hospital

🇯🇵

Aichi, Japan

Saitama Medical University International Medical Center

🇯🇵

Hidaka, Japan

Tsuchiya General Hospital

🇯🇵

Hiroshima, Japan

Iizuka Hospital

🇯🇵

Iizuka, Japan

Nippon Medical School Chiba Hokusoh Hospital

🇯🇵

Inzai, Japan

Kokura Memorial Hospital

🇯🇵

Kitakyusyu, Japan

Kawasaki Medical School Hospital

🇯🇵

Kurashiki, Japan

Japanese Red Cross Kyoto Daini Hospital

🇯🇵

Kyoto, Japan

National Hospital Organization Osaka National Hospital

🇯🇵

Osaka, Japan

Nippon Medical School Hospital

🇯🇵

Tokyo, Japan

Asahikawa-Kosei General Hospital

🇯🇵

Asahikawa, Japan

Hekinan Municipal Hospital

🇯🇵

Hekinan, Japan

Juntendo University Shizuoka Hospital

🇯🇵

Izunokuni, Japan

Setsunan General Hospital

🇯🇵

Kadoma, Japan

Kanazawa Cardiovascular Hospital

🇯🇵

Kanazawa, Japan

Japan Labour Health and Welfare Organization, Kansai Rosai Hospital

🇯🇵

Amagasaki, Japan

Fukui Cardiovascular Center

🇯🇵

Fukui, Japan

Kansai Medical University Hirakata Hospital

🇯🇵

Hirakata, Japan

Hiratsuka Kyosai Hospital

🇯🇵

Hiratsuka, Japan

Hirosaki University School of Medicine and Hospital

🇯🇵

Hirosaki, Japan

Hiroshima University Hospital

🇯🇵

Hiroshima, Japan

Chikamori Hospital

🇯🇵

Kochi, Japan

Rinku General Medical Center

🇯🇵

Izumisano, Japan

Nara Medical University Hospital

🇯🇵

Kashihara, Japan

Japan Labour Health and Welfare Organization, Kanto Rosai Hospital

🇯🇵

Kawasaki, Japan

Kagawa University Hospital

🇯🇵

Kida, Japan

Hoshi General Hospital

🇯🇵

Koriyama, Japan

Saiseikai Kumamoto Hospital

🇯🇵

Kumamoto, Japan

Osaka Police Hospital

🇯🇵

Osaka, Japan

Tohoku Koseinenkin Hospital

🇯🇵

Sendai, Japan

Ayase Heart Hospital

🇯🇵

Tokyo, Japan

Nihon University School of Medicine Itabashi Hospital

🇯🇵

Tokyo, Japan

Showa University Hospital

🇯🇵

Tokyo, Japan

Tokyo Metropolitan Hiroo Hospital

🇯🇵

Tokyo, Japan

Tokyo Women's Medical University Hospital

🇯🇵

Tokyo, Japan

Tsuchiura Kyodo Hospital

🇯🇵

Tsuchiura, Japan

Kikuna Memorial Hospital

🇯🇵

Yokohama, Japan

Kimitsu Chuo Hospital

🇯🇵

Kisarazu, Japan

Kumamoto Chuo Hospital

🇯🇵

Kumamoto, Japan

Miyazaki Medical Association Hospital

🇯🇵

Miyazaki, Japan

Shiga Medical Center for Adults

🇯🇵

Moriyama, Japan

Sakakibara Heart Institute of Okayama

🇯🇵

Okayama, Japan

Itabashi Chuo Medical Center

🇯🇵

Tokyo, Japan

Juntendo University Hospital

🇯🇵

Tokyo, Japan

Mitsui Memorial Hospital

🇯🇵

Tokyo, Japan

Toyama Prefectural Central Hospital

🇯🇵

Toyama, Japan

Japan Labour Health and Welfare Organization, Yokohama Rosai Hospital

🇯🇵

Yokohama, Japan

Showa University Fujigaoka Hospital

🇯🇵

Yokohama, Japan

Tsuyama Central Hospital

🇯🇵

Tsuyama, Japan

Teikyo University Hospital

🇯🇵

Tokyo, Japan

Tokyo Medical University Hospital

🇯🇵

Tokyo, Japan

Toranomon Hospital

🇯🇵

Tokyo, Japan

The Cardiovascular Institute Hospital

🇯🇵

Tokyo, Japan

Fujita Health University Hospital

🇯🇵

Toyoake, Japan

Yamagata Prefectural Central Hospital

🇯🇵

Yamagata, Japan

Saiseikai Yamaguchi Hospital

🇯🇵

Yamaguchi, Japan

Saiseikai Yokohamashi Tobu Hospital

🇯🇵

Yokohama, Japan

Toyama Red Cross Hospital

🇯🇵

Toyama, Japan

Uwajima City Hospital

🇯🇵

Uwajima, Japan

Kanagawa Cardiovascular and Respiratory Center

🇯🇵

Yokohama, Japan

Yokosuka General Hospital Uwamachi

🇯🇵

Yokosuka, Japan

Wakayama Medical University Hospital

🇯🇵

Wakayama, Japan

Japan Labour Health and Welfare Organization, Kumamoto Rosai hospital

🇯🇵

Yatsushiro, Japan

Showa University Northern Yokohama Hospital

🇯🇵

Yokohama, Japan

Yokohama City University General Medical Center

🇯🇵

Yokohama, Japan

Tottori University Hospital

🇯🇵

Yonago, Japan

Yokohama Sakae Kyosai Hospital

🇯🇵

Yokohama, Japan

Sendai Open Hospital

🇯🇵

Sendai, Japan

Koseikai Takeda Hospital

🇯🇵

Kyoto, Japan

Sakakibara Memorial Hospital

🇯🇵

Fuchu, Japan

Koto Memorial Hospital

🇯🇵

Higashiomi, Japan

Oita Cardiovascular Hospital

🇯🇵

Oita, Japan

Saiseikai Imabari Hospital

🇯🇵

Imabari, Japan

OitaOka Hospital

🇯🇵

Oita, Japan

Iwaki Kyoritsu Hospital

🇯🇵

Iwaki, Japan

Ishikawa Prefectural Central Hospital

🇯🇵

Kanazawa, Japan

Kobe University Hospital

🇯🇵

Kobe, Japan

Kurume University Hospital

🇯🇵

Kurume, Japan

St.Mary's Hospital

🇯🇵

Kurume, Japan

Kyoto-Katsura Hospital

🇯🇵

Kyoto, Japan

Mie Heart Center

🇯🇵

Mie, Japan

Miki City Hospital

🇯🇵

Miki, Japan

Memorial Heart Center Iwate Medical University

🇯🇵

Morioka, Japan

Musashino Red Cross Hospital

🇯🇵

Musashino, Japan

Tachikawa General Hospital

🇯🇵

Nagaoka, Japan

Kouseikai Hospital

🇯🇵

Nagasaki, Japan

Nagoya Memorial Hospital

🇯🇵

Nagoya, Japan

Okayama Red Cross General Hospital

🇯🇵

Okayama, Japan

Nagoya Daini Red Cross Hospital

🇯🇵

Nagoya, Japan

Ogaki Municipal Hospital

🇯🇵

Ogaki, Japan

Omihachiman Community Medical Center

🇯🇵

Omihachiman, Japan

Okayama University Hospital

🇯🇵

Okayama, Japan

Osaka General Medical Center

🇯🇵

Osaka, Japan

Osaka City University Hospital

🇯🇵

Osaka, Japan

Iwatsuki-minami Hospital

🇯🇵

Saitama, Japan

Japan Labour Health and Welfare Organization, Osaka Rosai Hospital

🇯🇵

Sakai, Japan

Caress Sapporo Hokko Memorial Hospital

🇯🇵

Sapporo, Japan

Hokkaido Social Insurance Hospital

🇯🇵

Sapporo, Japan

Sapporo Orthopaedic Cardio-vascular Hospital

🇯🇵

Sapporo, Japan

Teine Keijinkai Hospital

🇯🇵

Sapporo, Japan

Sendai Kousei Hospital

🇯🇵

Sendai, Japan

Jichi Medical University Hospital

🇯🇵

Shimotsuke, Japan

National Cerebral and Cardiovascular Center

🇯🇵

Suita, Japan

Osaka University Graduate School of Medicine

🇯🇵

Suita, Japan

Kagawa Prefectural Central Hospital

🇯🇵

Takamatsu, Japan

Edogawa Hospital

🇯🇵

Tokyo, Japan

Jikei University Hospital

🇯🇵

Tokyo, Japan

Kanto Medical Center NTT EC

🇯🇵

Tokyo, Japan

Keio University Hospital

🇯🇵

Tokyo, Japan

St. Luke's International Hospital

🇯🇵

Tokyo, Japan

Toho University Ohashi Medical Center

🇯🇵

Tokyo, Japan

Tomishiro Central Hospital

🇯🇵

Tomishiro, Japan

© Copyright 2025. All Rights Reserved by MedPath